Arthrex Biotech
AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.
Arthrex Biotech has raised €1.5M across 1 funding round from 1 investor, most recently a round in Sep 2020. Based in Valencia, Spain; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.5M
€1,500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2020-09
latest 2020-09
Funding by year
EUR raised per yearArthrex Biotech — funding by year — interactive chart.
Data table
| Arthrex Biotech — funding by year | |
|---|---|
| 2020 | €1.5M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-01 | Other | €1.5M | Invivo Capital Partners | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData